Featured Reviews in Antimicrobial Materials
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antimicrobial Materials and Surfaces".
Deadline for manuscript submissions: closed (29 February 2024) | Viewed by 6959
Special Issue Editors
Interests: organic chemistry; synthesis; drug delivery; coniugates; hallosyte nanotubes; carrier systems; nanomaterials; biocompatible materials
Special Issues, Collections and Topics in MDPI journals
Interests: clay minerals; halloysite; drug carrier; chemical modification
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Bacterial infections are still a major cause of mortality in the world. Biofilms are agglomerates of microorganisms that stay attached to a substrate in an irreversible manner. Currently, one of the main goals of the World Health Organization is addressed to combat microbial resistance that represents a serious problem facing the world. Up to now, to neutralize antimicrobial resistance, different systems have been developed as alternatives to common employed antibiotics.
The design and development of antimicrobial materials are a challenge in several fields.
This Special Issue of Antibiotics in the section “Antimicrobial Materials and Surfaces” covers a selection of reviews in the field of antimicrobial materials. All manuscripts submitted for the Special Issue may cover, but are not limited to, the synthesis of new antimicrobial materials for the delivery of antimicrobial agents, dealing with their biological properties for applications in healthcare, packaging, the environment, etc.
Mini-reviews and featured articles presenting an overview of the state of the art with projections on future perspectives and trends in this domain will also be considered.
Dr. Serena Riela
Dr. Marina Massaro
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
